Endocrine

Nursing Management: Patients With Endocrine Disorders

Pituitary Gland

  • Role:

    • Regulates most endocrine organs.

    • “Master gland.”

  • Secretions:

  • Anterior pituitary secretes:

    • Adrenocorticotropic hormone (ACTH).

  • Posterior pituitary secretes:

    • Anti-diuretic hormone (ADH).

Pituitary Disorders

  • General Overview:

    • Hypersecretion is a common cause of disorders.

  • Types of Disorders:

    • Disorders can be caused by pituitary tumors:

    • Tumors are usually benign.

  • Risk Factors:

    • Multiple endocrine neoplasia type 1 (MEN1).

Medical Management of Pituitary Disorders

Hypophysectomy (surgical removal of pituitary gland):

  • Preoperative Management:

    • Baseline endocrine tests.

  • Postoperative Care:

    • Prevent infection and promote healing.

    • Antimicrobial agents.

    • Desmopressin and/or steroid replacement therapy.

    • Electrolyte surveillance.

Nursing Management for Pituitary Disorders

  • Critical Focus Areas:

    • Airway and breathing management.

    • Neurologic monitoring.

    • Fluid and electrolyte balance maintenance.

    • Hormonal replacement therapy.

    • Infection prevention strategies.

    • Pain management and comfort.

    • Patient education initiatives.

Disorders Associated with Hormone Oversecretion

  • Adrenocorticotropic hormone (ACTH):

    • Cushing syndrome.

  • Thyroid hormone:

    • Hyperthyroidism.

  • Growth hormone:

    • In adults: Acromegaly.

    • In children: Gigantism.

  • Antidiuretic hormone (ADH):

    • Syndrome of inappropriate antidiuretic hormone secretion (SIADH).

  • Parathyroid hormone:

    • Hyperparathyroidism.

  • Insulin:

    • Hypoglycemia.

Disorders Associated with Hormone Undersecretion

  • Adrenocorticotropic hormone (ACTH):

    • Addison disease.

  • Thyroid hormone:

    • Hypothyroidism or myxedema.

  • Growth hormone:

    • Congenital growth hormone deficiency.

  • Antidiuretic hormone (ADH):

    • Diabetes insipidus.

  • Parathyroid hormone:

    • Hypoparathyroidism.

  • Insulin:

    • Diabetes mellitus.

Syndrome of Inappropriate Antidiuretic Hormone (SIADH)

  • Pathophysiology:

    • Excessive secretion of ADH leads to water retention:

    • Low serum sodium levels.

    • Decreased urine output.

    • High urine osmolality.

    • High specific gravity of urine.

  • Risk Factors:

    • Biologic females.

    • Low body weight.

    • Carcinomas.

    • Central nervous system disorders.

    • Certain medications.

    • HIV infection.

  • Manifestations:

    • Neurological symptoms (confusion, seizures).

    • Gastrointestinal symptoms (nausea, vomiting).

    • Other systemic effects (fatigue).

Diagnosis & Management of SIADH

  • Diagnosis Approaches:

    • Brain and chest imaging studies.

    • Laboratory testing for serum and urine osmolality.

  • Management Strategies:

    • Administer 3% sodium chloride solution.

    • Diuretics to promote fluid loss.

    • Vasopressin antagonists (e.g., Tolvaptan, Conivaptan).

  • Nursing Priorities:

    • Neurologic assessment.

    • Strict input and output monitoring.

    • Daily weight measurement.

    • Fluid restriction measures.

    • Positioning with head of bed <10°.

    • Implement seizure and fall precautions.

Diabetes Insipidus (DI)

  • Description:

    • Involves decreased ADH secretion leading to excessive water loss through urine and increased thirst.

  • Types of DI:

    • Neurogenic (central).

    • Nephrogenic.

    • Dipsogenic (primary polydipsia).

    • Gestational (rare).

  • Clinical Manifestations:

    • Polyuria (excessive urination).

    • Polydipsia (excessive thirst).

    • Dry mucous membranes.

    • Poor skin turgor.

    • Weight loss.

    • Nocturia.

    • Increased heart rate.

    • Hypotension.

Diagnostic Tests for DI

  • Commonly Used Tests:

    • Urine tests to assess osmolarity and concentration.

    • Blood tests for electrolyte and hormone levels.

    • Vasopressin challenge test to evaluate the response to ADH.

    • Water deprivation test to determine the concentration ability of kidneys.

    • MRI/CT for imaging the pituitary gland.

Management of Diabetes Insipidus

  • Central DI:

    • Treat with Desmopressin (DDAVP).

    • Ensure adequate fluid replacement.

    • Address any underlying causes.

  • Nephrogenic DI:

    • Use thiazide diuretics and encourage a low-sodium diet and adequate hydration.

  • Dipsogenic DI:

    • Restrict fluid intake and avoid alcohol consumption.

  • Nursing Priorities:

    • Strict input and output monitoring.

    • Neurologic assessment ongoing.

    • Daily weight evaluations.

    • Patient and family education regarding DI management.

Acromegaly

  • Definition:

    • Characterized by excess secretion of growth hormone (GH).

  • Common Cause:

    • Most often due to pituitary adenoma.

  • Less Common Causes:

    • Hypothalamic dysfunction.

    • Ectopic secretion of GH or GH-releasing hormone (GHRH).

Clinical Manifestations of Acromegaly

  • Physical Changes:

    • Soft tissue changes and skeletal abnormalities.

  • Neurologic Signs:

    • Headaches, vision changes.

  • Metabolic Changes:

    • Glucose intolerance, hyperglycemia.

  • Cardiovascular Effects:

    • Hypertension, cardiac enlargement.

  • Reproductive Changes:

    • Changes in libido, menstrual irregularities.

Diagnostic Tests for Acromegaly

  • Common Assessments:

    • Measure insulin-like growth factor (IGF-1) levels in blood.

    • MRI of the pituitary gland.

    • CT scan for assessing pituitary abnormalities.

Management of Acromegaly

  • Surgical Options:

    • Surgical removal of the pituitary adenoma (transsphenoidal hypophysectomy).

  • Medical Management:

    • Somatostatin analogs to inhibit GH secretion.

    • GH receptor antagonists to block GH effects.

    • Dopamine agonists as possible adjunct therapy.

  • Other Options:

    • Radiation therapy for residual disease.

  • Nursing Management:

    • Provide care post-hypophysectomy, including hormone replacement needs.

Disorders of the Adrenal Glands

  • Key Disorders:

    • Pheochromocytoma (adrenal medulla).

    • Addison’s disease (adrenocortical insufficiency).

    • Cushing’s syndrome.

    • Hyperaldosteronism (Conn’s syndrome).

Pheochromocytoma

  • Pathophysiology:

    • Rare catecholamine-secreting tumor of the adrenal medulla:

    • Usually benign tumor originates from chromaffin cells.

    • Causes excess secretion of catecholamines (epinephrine, norepinephrine, dopamine).

    • Leads to symptoms such as hypertension, increased heart rate, and increased metabolic rate.

Clinical Manifestations of Pheochromocytoma

  • Features:

    • Severe hypertension.

    • Headaches.

    • Hyperhidrosis (excessive sweating).

    • Hypermetabolism and possible weight loss.

    • Hyperglycemia due to catecholamine-induced glycogenolysis.

Diagnostic Tests for Pheochromocytoma

  • Laboratory Tests:

    • 24-hour urine collection for catecholamines.

  • Imaging Studies:

    • CT or MRI scan to locate the tumor.

    • Clonidine suppression test to differentiate from other causes of hypertension.

Management of Pheochromocytoma

  • Surgical Options:

    • Adrenalectomy (surgical removal of the adrenal gland).

  • Preoperative Preparation:

    • Alpha-adrenergic blocker prior to surgery to control blood pressure.

    • Beta-blocker as needed for hypertension.

  • Nursing Priorities:

    • Monitor vital signs closely.

    • Assess for stressors or precipitating activities.

    • Manage any fluid and electrolyte imbalances.

    • Assess blood glucose levels.

    • Offer comprehensive patient education about disease management.

Addison Disease

  • Pathophysiology:

    • Involves deficiency of adrenocorticotropic hormone (ACTH).

    • Mostly autoimmune destruction of the adrenal cortex is responsible for 90% of cases.

Etiology of Addison Disease (ADD-IS-ON)

  • Potential causes include:

    • Autoimmune destruction of adrenal glands.

    • Adrenal disease or insufficiency:

    • Drug-induced effects (certain medications).

    • Idiopathic causes.

    • Secondary causes related to other endocrine disorders.

    • Oncologic conditions affecting the adrenal glands.

Clinical Manifestations of Addison Disease

  • Symptoms:

    • Fatigue and muscle weakness.

    • Weight loss and anorexia.

    • Hyperpigmentation (often described as “bronze skin”).

    • Hypotension and orthostatic changes.

    • Hyponatremia and hyperkalemia.

    • Hypoglycemia and salt craving.

  • Diagnosis:

    • Laboratory tests are key, assessing:

    • Serum sodium and potassium levels.

    • Glucose.

    • Cortisol level, particularly during stress.

    • Imaging studies like CT and MRI to visualize adrenal glands.

Addisonian Crisis (Acute Adrenal Insufficiency)

  • Definition:

    • An acute, life-threatening condition common in advanced Addison's disease.

  • Triggers:

    • Often precipitated by stress-related events (trauma, illness).

  • Manifestations:

    • Severe hypotension and tachycardia.

    • Signs of dehydration.

    • Electrolyte imbalances (hyponatremia, hyperkalemia).

    • Hypoglycemia and potentially confusion or coma.

Emergency Management of Addisonian Crisis

  • Key Actions Include:

    • Treat the underlying cause of the crisis.

    • Correct electrolyte imbalances as needed.

    • Administer corticosteroids, specifically IV hydrocortisone.

    • Ensure continuous monitoring of vital signs and patient's condition.

Nursing Priorities for Addison Disease

  • Focus Areas:

    • Monitor for signs of crisis closely.

    • Restore and maintain fluid status (IV fluids as needed).

    • Implement stress-reduction techniques in the care plan.

    • Provide patient education on the importance of medication adherence.

    • Encourage patients to wear medical alert bracelets for emergencies.

Cushing Syndrome

  • Definition:

    • Characterized by high levels of serum cortisol.

  • Causes:

    • Pituitary tumor that overproduces ACTH.

    • Adrenal tumor overproducing corticosteroids.

    • Long-term glucocorticoid pharmacologic therapy can also precipitate this condition.

Pathophysiology of Cushing Syndrome

  • Mechanisms:

    • Involves:

    • Protein catabolism leading to muscle wasting.

    • Redistribution of body fat (truncal obesity).

    • Hyperglycemia due to increased gluconeogenesis.

    • Suppressed immune response leading to increased infection risk.

    • Increased sodium and water retention causing hypertension.

Clinical Manifestations of Cushing Syndrome

  • Physical Features:

    • Central/truncal obesity with a characteristic “moon-faced” appearance.

    • Thin, fragile skin that bruises easily.

    • Poor wound healing.

    • Purple striae on abdomen, breasts, and thighs.

    • Musculoskeletal changes including weakness and osteoporosis.

    • Elevated blood glucose levels (glucose intolerance).

    • Hypertension and amenorrhea in women.

    • Emotional disturbances such as mood swings and anxiety.

    • Hirsutism (excessive hair growth).

Diagnostic Tests for Cushing Syndrome

  • Common Tests:

    • 24-hour urine free cortisol (requires two measurements for accuracy).

    • Dexamethasone suppression test to assess cortisol suppression dynamics.

    • Blood tests including plasma ACTH levels to investigate the source of excess cortisol.

    • Imaging studies (CT, MRI) to visualize the adrenal glands for tumors or lesions.

    • Late night salivary cortisol test (indicative of loss of diurnal rhythm of cortisol secretion).

Medical Management of Cushing Syndrome

  • Management Strategies Depend on Etiology:

    • Exogenous causes focus on tapering glucocorticoids.

    • Pituitary adenoma management generally requires transsphenoidal hypophysectomy.

    • Adrenal tumors necessitate adrenalectomy.

    • Ectopic ACTH tumor management involves addressing the primary site.

  • Medications:

    • Ketoconazole, mitotane, and metyrapone can reduce cortisol production.

Nursing Priorities in Cushing Syndrome

  • Key Responsibilities:

    • Monitor vital signs regularly, especially blood pressure.

    • Assess for signs of electrolyte imbalances (especially potassium and sodium).

    • Reduce the risk of infection through a sterile environment.

    • Promote skin integrity and care for fragile skin.

    • Be aware of and manage Addisonian crisis as a complication.

    • Encourage a low sodium, high potassium diet when appropriate.

    • Support thought processes and mental health care for emotional disturbances.

Primary Aldosteronism

  • Description:

    • Characterized by overproduction of aldosterone.

  • Physiological Effects:

    • Results in decreased levels of potassium and hydrogen ions (leading to alkalosis).

  • Treatment:

    • Surgical removal of adrenal tumor (adrenalectomy) is typically indicated.

Thyroid Gland Disorders

  • Main Disorders:

    • Hypothyroidism.

    • Hyperthyroidism.

    • Thyroid tumors and cancers.

Hypothyroidism

  • Pathophysiology:

    • Involves deficiency of thyroid hormone (specifically thyroxine), leading to slowed metabolic processes.

  • Types of Hypothyroidism:

    • Primary, secondary, and tertiary:

    • Primary: Dysfunction of the thyroid gland itself.

    • Secondary: Dysfunction of the pituitary gland affecting TSH production.

    • Tertiary: Dysfunction of the hypothalamus impacting TRH production.

Etiology of Hypothyroidism (HASHED)

  • Causes include:

    • Hashimoto disease (autoimmune).

    • Various autoimmune disorders.

    • Surgical removal of the thyroid gland.

    • Hormonal imbalances affecting production.

    • Endemic iodine deficiency leading to inadequate thyroid hormone synthesis.

    • Drug-induced hypothyroidism due to medications such as lithium or amiodarone.

Risk Factors for Hypothyroidism

  • Demographics:

    • More common in biologically female patients.

    • Typically affects those aged 30 to 60 years.

    • Family history of thyroid disease significantly increases risk.

    • Previous thyroid surgeries or radiation exposure are notable risk factors.

Clinical Manifestations of Hypothyroidism

  • Early Symptoms:

    • Fatigue and drowsiness (somnolence).

    • Loss of libido and amenorrhea.

    • Sluggishness and non-pitting edema.

    • Dry skin and brittle nails.

    • Hair loss.

  • Late Symptoms:

    • Slow speech and subdued emotional responses.

    • Absence of sweating (anhidrosis) and cold intolerance.

    • Constipation, weight gain, and dyspnea.

    • Bradycardia and potential cardiomegaly.

Diagnostic Tests for Hypothyroidism

  • Laboratory Tests:

    • Serum TSH levels.

    • T3 (triiodothyronine) levels – usually low.

    • T4 (thyroxine) levels – generally low.

    • Presence of anti-thyroid peroxidase (anti-TPO) antibodies is indicative of Hashimoto's disease.

Management of Hypothyroidism

  • Primary Treatment:

    • Administration of Levothyroxine (Synthroid).

  • Monitoring:

    • Regular monitoring of TSH levels every 6 to 8 weeks.

    • Dosage adjustments based on laboratory findings.

  • Nursing Management:

    • Prevent myxedema crisis by ensuring adequate treatment and monitoring.

    • Monitor vital signs regularly, especially during initial treatment.

    • Evaluate for signs of depression in patients, especially in chronic cases.

    • Provide patient education on medication adherence and related lifestyle changes.

Complications of Hypothyroidism

  • Myxedema:

    • A severe form of hypothyroidism described as “slow coma” or myxedema coma.

    • Characterized by:

    • Decreased metabolic rate and cardiac output.

    • Reduced oxygen consumption and difficulty with temperature regulation.

    • Accumulation of mucopolysaccharides leading to exacerbated edema and metabolic disturbances.

Clinical Manifestations of Myxedema

  • Signs to Look For:

    • Severe hypothermia.

    • Lethargy or coma presentation.

    • Oxygen deficiency evident.

    • Weak heart function as indicated on assessments.

    • Constipation and significant overweight issues.

    • Mental changes, particularly in cognition.

Nursing Priorities in Myxedema

  • Management Objectives:

    • Ensure proper thyroid hormone replacement as necessary.

    • Administer corticosteroids in case of coexisting adrenal insufficiency.

    • Provide for airway and ventilation support as needed.

    • Continual monitoring of vital signs and indication of changes.

    • Use warming blankets to manage temperature.

    • Assess cardiac function regularly to identify potential dysrhythmias.

    • Provide infection prevention measures to reduce risk.

    • Maintain fluid and electrolyte balance accommodations.

    • Support for emotional well-being should be integrated into care plans.

    • Consider the use of IV glucose if hypoglycemia is present.

Hyperthyroidism

  • Pathophysiological Mechanism:

    • Characterized by excessive production of thyroid hormones (T3 and T4), leading to increased metabolic rate.

Etiology of Hyperthyroidism (GREAT)

  • Common Causes:

    • Graves disease (autoimmune hyperthyroidism).

    • Runaway thyroid nodules or goiter leading to excess hormone production.

    • Excessive iodine intake or after using certain medications like amiodarone.

    • Chronic thyroiditis indicating long-standing thyroid inflammation.

Clinical Manifestations of Hyperthyroidism

  • Symptoms Characterizing Increased Metabolism (SPEED-UP-METABOLISM):

    • Profound sweating and increased appetite.

    • Palpitations signifying increased heart rate.

    • Exophthalmos (protrusion of the eyes).

    • Emotional lability presenting as mood swings.

    • Diarrhea vs. weight loss discrepancy.

    • Unexplained fatigue and changes in menses.

    • Muscle weakness, thyromegaly (enlarged thyroid), changes in hair quality.

    • Signs of osteoporosis and sleep disturbance.

    • Increased blood pressure and other skin changes.

Diagnosis of Hyperthyroidism

  • Diagnostic Laboratory Studies:

    • Serum TSH levels (decreased).

    • T3 levels (elevated).

    • T4 levels (elevated).

    • Radioactive uptake test for thyroid function assessment.

    • Thyroid ultrasound and other imaging studies for structural evaluation.

Complications of Hyperthyroidism

  • Potential Risks:

    • Thyroid storm: characterized by severe tachycardia, high fever, and altered mental status.

    • Heart failure due to increased workload on the heart.

    • Osteoporosis and potential fractures due to bone density reduction.

    • Cardiomyopathy and various eye problems related to exophthalmos.

Medical Management of Hyperthyroidism

  • Treatment Options:

    • Radioisotope Iodine-131 (131I) therapy for targeted thyroid ablation.

    • Antithyroid medications (e.g., Propylthiouracil (PTU), Methimazole).

    • Iodine solutions and steroids (Dexamethasone) for temporary symptom control.

    • Beta-blockers can facilitate rapid management of tachycardia.

Nursing Priorities in Hyperthyroidism

  • Key Focus Areas:

    • Monitor vital signs carefully, especially in regard to heart rate and blood pressure.

    • Maintain a calm environment to decrease patient anxiety and prevent exacerbation of symptoms.

    • Keep an eye out for signs indicative of thyroid storm for prompt intervention.

    • Nutritional support for weight loss management and diet adjustments (avoid iodine-rich foods).

    • Provide necessary eye care for patients with exophthalmos.

    • Offer comprehensive patient education about their condition and ensuring proper management strategies.

Question Example 1

  • Consideration:

    • A client with newly diagnosed hyperthyroidism presents with:

    • Heart rate of 132 bpm.

    • Blood pressure of 160/88 mm Hg.

    • Temperature of 102°F (38.9°C).

    • Restlessness.

    • Action Priority: Determine which nursing action should be taken first based on the symptoms presented.

Disorders of the Parathyroid Glands

  • Common Disorders:

    • Hyperparathyroidism (leading to a hypercalcemic crisis).

    • Hypoparathyroidism (hyposecretion of parathyroid hormone / PTH).

Hyperparathyroidism

  • Main Features:

    • Excess production of parathyroid hormone (PTH).

    • Resulting elevated serum calcium and low serum phosphate.

  • Types:

    • Primary: Often caused by adenomas.

    • Secondary: Usually due to chronic kidney disease.

    • Tertiary: Hyperplasia after long-term secondary hyperparathyroidism.

Clinical Manifestations of Hyperparathyroidism

  • Systemic Effects:

    • Renal: Formation of kidney stones.

    • Musculoskeletal: Bone pain and higher fracture risk.

    • Gastrointestinal: Symptoms like nausea, vomiting, abdominal pain.

    • Neurological: Possible confusion or altered mental status.

Diagnostic Findings for Hyperparathyroidism

  • Lab Tests:

    • Serum calcium levels increased.

    • Serum phosphate typically decreased.

    • Elevated PTH levels confirmed by radioimmunoassay.

    • Imaging studies may show bone demineralization.

Medical & Nursing Management for Hyperparathyroidism

  • Surgical Management:

    • Parathyroidectomy: removal of affected glands.

  • Nursing Management:

    • Encourage fluid intake and mobility to promote kidney health.

    • Continuous monitoring of electrolytes and cardiac rhythms.

    • Dietary considerations for calcium intake must be monitored closely.

    • Provide education regarding managing hypercalcemic crises post-operative care and long-term follow-up.

Hypoparathyroidism

  • Description:

    • Involves hyposecretion of parathyroid hormone (PTH).

  • Causes:

    • Parathyroidectomy, exposure to heavy metals, magnesium depletion, autoimmune destruction, infections, or malignancies.

Clinical Manifestations of Hypoparathyroidism

  • Neuromuscular Symptoms:

    • Tetany (muscle spasms) with positive Trousseau's and Chvostek's signs.

    • Paresthesia and potential laryngospasm or bronchospasm.

    • Cardiac dysrhythmias due to electrolyte imbalances.

Diagnostics for Hypoparathyroidism

  • Common Laboratory Findings:

    • Decreased serum calcium levels and increased serum phosphate levels.

    • Low PTH levels present.

    • Normal or low magnesium with possible ECG changes indicating dysrhythmias.

Management of Hypoparathyroidism

  • Medical Treatment Options:

    • Administer IV calcium gluconate for acute cases.

    • Prescribe oral calcium carbonate and Vitamin D supplements for longer management.

    • Address hypomagnesemia if present and dietary modifications for a high-calcium, low-phosphate intake.

  • Nursing Management:

    • Continuous cardiac and respiratory monitoring to detect complications.

    • Enforce seizure precautions for patient safety.

    • Educate patients about symptoms recognition and dietary modifications to manage their condition effectively.